ロード中...
The revolution of the anti-diabetic drugs in cardiology
Beginning in December 2008, under the auspices of Food and Drug Administration, numerous controlled clinical trial were planned, and in part completed, concerning the cardiovascular (CV) effects of hypoglycaemic drug in patients with Type 2 diabetes mellitus. At least 9 studies have been concluded,...
保存先:
| 出版年: | Eur Heart J Suppl |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7270967/ https://ncbi.nlm.nih.gov/pubmed/32523463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa084 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|